Share

September 01, 2015; 85 (9) Article

N-terminal pro–brain natriuretic peptide and abnormal brain aging

The AGES–Reykjavik Study

Behnam Sabayan, Mark A. van Buchem, Anton J.M. de Craen, Sigurdur Sigurdsson, Qian Zhang, Tamara B. Harris, Vilmundur Gudnason, Andrew E. Arai, Lenore J. Launer
First published July 31, 2015, DOI: https://doi.org/10.1212/WNL.0000000000001885
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
242

Share

Article Information

vol. 85 no. 9 813-820
DOI: 
https://doi.org/10.1212/WNL.0000000000001885
PubMed: 
26231259
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received January 9, 2015
  • Accepted in final form May 6, 2015
  • First Published July 31, 2015.

Article Versions

Copyright & Usage: 
© 2015 American Academy of Neurology

Author Disclosures

    1. Behnam Sabayan, MD, PhD,
    2. Mark A. van Buchem, MD, PhD,
    3. Anton J.M. de Craen, PhD,
    4. Sigurdur Sigurdsson, MSc,
    5. Qian Zhang, MSc,
    6. Tamara B. Harris, MD, MSc,
    7. Vilmundur Gudnason, MD, PhD,
    8. Andrew E. Arai, MD and
    9. Lenore J. Launer, PhD
  1. Behnam Sabayan, MD, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Mark A. van Buchem, MD, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Anton J.M. de Craen, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. PLoS Medicine, academic editor, 2013-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Sigurdur Sigurdsson, MSc,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. This work was supported by National Institutes of Health (N01-AG-12100); National Institute on Aging Intramural Research Program; Hjartavernd (Icelandic Heart Association); Althingi (the Icelandic Parliament). The current study was conducted without any influence from the above.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Qian Zhang, MSc,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Tamara B. Harris, MD, MSc,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. J of Gerontology: Medical Science, Editorial advisory board member, 2008-present.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Principal Investigator, Age, Gene/Environment Susceptibility-Reykjavik Study, 2002-present, Contact: N01-AG-12100 Principal Investigator, Health, Aging, and Body Composition Study, Contracts: AG-6-2101, AG-6-2103, AG-6- 2106, and AG021918, 1998-present.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Vilmundur Gudnason, MD, PhD,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH/AG-1-2100/PI/2001-2017

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Icelandic Heart Association

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Andrew E. Arai, MD and
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. US Patent# 6,031,374 Title:Method for extracting deformations from velocity-encoded magnetic resonance images of the heart. Description: This represents a computer analysis of myocardial function. US Patent# 5,997,883 Title: Retrospective ordering of segmented MRI cardiac data using cardiac phase. Description: This is a methodology for prospectively acquiring MRI data across the cardiac cycle and retrospectively sorting the data in a way that can create images across the cardiac cycle depsite heart rate variability during the raw image acquisition.

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical procedures or imaging studies:

    1. 1. National Institutes of Health, NHLBI Advanced Cardiovascular Imaging Laboratory.

    Research Support, Commercial Entities:

    1. 1. Siemens - Research support for cardiac MRI (technical) 2. Toshiba - Research support for cardiac CT

    Research Support, Government Entities:

    1. National Institutes of Health,NHLBI, Division of Intramural Research, I am the PI on 6 projects (years follow the hyphen in the grant number): ZIA HL004607-16 Technical Development of Cardiovascular MRI ZIA HL006136-04 Area at Risk, Myocardial Infarction, and Myocardial Salvage ZIA HL006137-04 Quantification of Myocardial Perfusion ZIA HL006138-04 Cardiovascular CT Research ZIE HL006139-04 Advanced Cardiovascular Imaging Fellowship ZID HL006140-04 Clinical Advanced Cardiovascular Imaging

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Lenore J. Launer, PhD
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. National Institute on Aging Intramural Research Program, Employee, 1999-present

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Radiology (B.S., M.A.v.B.) and Gerontology and Geriatrics (B.S., A.J.M.d.C.), Leiden University Medical Center, the Netherlands; Icelandic Heart Association (S.S., V.G.), Reykjavik, Iceland; Intramural Research Program (Q.Z., T.B.H., L.J.L.), National Institute on Aging, NIH, Bethesda, MD; Faculty of Medicine (V.G.), University of Iceland, Reykjavik; and Cardiovascular and Pulmonary Branch (A.E.A.), National Heart, Lung, and Blood Institute, NIH, Bethesda, MD.
  1. Correspondence to Dr. Launer: launerl{at}nia.nih.gov
View Full Text

Article usage

Article usage: July 2015 to January 2021

AbstractFullPdfSource
Jul 20153402Highwire
Aug 2015669236Highwire
Sep 20158311017Highwire
Oct 20151231110Highwire
Nov 20157596Highwire
Dec 20155255Highwire
Jan 20165064Highwire
Feb 20164833Highwire
Mar 20165235Highwire
Apr 20162955Highwire
May 20161811Highwire
Jun 20163011Highwire
Jul 20161800Highwire
Aug 20163410Highwire
Sep 20162200Highwire
Sep 2016093pmc
Oct 20163400Highwire
Oct 20160167pmc
Nov 20162912Highwire
Nov 2016094pmc
Dec 20162200Highwire
Dec 2016041pmc
Jan 20172500Highwire
Jan 20170225pmc
Feb 20172421Highwire
Feb 2017073pmc
Mar 20171575Highwire
Mar 2017072pmc
Apr 20171511Highwire
Apr 2017578pmc
May 20172300Highwire
May 20175108pmc
Jun 2017600Highwire
Jun 2017022pmc
Jul 2017600Highwire
Jul 2017366pmc
Aug 2017600Highwire
Aug 2017134pmc
Sep 2017600Highwire
Sep 2017244pmc
Oct 20171400Highwire
Oct 2017145pmc
Nov 20171101Highwire
Nov 20176127pmc
Dec 20171501Highwire
Jan 2018500Highwire
Feb 2018500Highwire
Mar 2018700Highwire
Apr 2018500Highwire
Apr 201832122pmc
May 2018100Highwire
Jun 2018600Highwire
Jun 201841416pmc
Jul 2018720Highwire
Aug 2018900Highwire
Aug 201821011pmc
Sep 2018500Highwire
Oct 2018500Highwire
Dec 20181311Highwire
Jan 2019701Highwire
Feb 2019911Highwire
Mar 2019510Highwire
Apr 2019600Highwire
May 20191501Highwire
Jun 2019900Highwire
Jul 2019700Highwire
Aug 2019911Highwire
Sep 20192013Highwire
Oct 20191601Highwire
Nov 20192101Highwire
Dec 20191200Highwire
Jan 20201022Highwire
Feb 20201621Highwire
Mar 20201100Highwire
Apr 2020800Highwire
May 20201100Highwire
Jun 20201711Highwire
Jul 20201610Highwire
Aug 2020500Highwire
Sep 20201800Highwire
Oct 20201011Highwire
Nov 20202311Highwire
Dec 20204012Highwire
Jan 20213010Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me